Adaptogenic Mushrooms And Cortisol Research

Table of Contents

• What Are Adaptogenic Mushrooms?
• How Mushrooms Influence Cortisol and the HPA Axis
• Reishi and Cortisol: The Most-Researched Connection
• Lion's Mane and Stress: What Research Shows
• Cordyceps, Chaga, and Other Adaptogenic Fungi for Stress
• Key Clinical Data: Mushroom Cortisol Research in Numbers
• Ashwagandha vs Mushroom Adaptogens: How Do They Compare?
• 2024 Research Updates: What's New in the Field
• Are Adaptogenic Mushrooms Safe for Long-Term Use?
• How to Choose and Use Mushroom Adaptogens for Stress
• Frequently Asked Questions
• Final Thoughts

Introduction

Chronic stress is not just a mood problem. It is a hormonal one.

When your body encounters stress — whether physical, psychological, or environmental — it triggers a cascade of biochemical events that ultimately causes your adrenal glands to release cortisol. In short bursts, cortisol is helpful. It sharpens focus, mobilizes energy, and prepares the body to respond to a threat. But when cortisol stays elevated for weeks or months on end, it begins to break down muscle tissue, suppress immune function, disrupt sleep, increase visceral fat, and damage cognitive performance.

This is where adaptogens enter the conversation.

For centuries, traditional medicine systems in Asia and Eastern Europe have used specific mushrooms and herbs to help the body cope with stress more efficiently. In modern clinical language, these are called adaptogens — compounds that help normalize physiological responses to stressors without causing dependence or significant side effects.

Among all adaptogens being studied today, adaptogenic mushrooms and cortisol regulation has become one of the most actively researched intersections in functional medicine. Species like reishi (Ganoderma lucidum), lion's mane (Hericium erinaceus), and cordyceps (Cordyceps sinensis) are no longer just wellness trends. They are subjects of peer-reviewed clinical trials, systematic reviews, and mechanistic studies exploring how adaptogenic fungi interact with the hormonal stress response at a biological level.

This article brings together the most current science available, including clinical statistics, 2024 study findings, safety data, and a practical comparison with plant-based adaptogens like ashwagandha. Whether you're a practitioner, a researcher, or someone trying to understand whether a mushroom supplement might actually help with stress, this guide is written to give you the clearest, most evidence-grounded picture available.

What Are Adaptogenic Mushrooms?

The term "adaptogen" was first coined in 1947 by Soviet pharmacologist Nikolai Lazarev. He used it to describe substances that increase the body's "state of nonspecific resistance" to stress. The classification was later formalized to include three defining criteria: a substance must be nontoxic at normal doses, it must produce a nonspecific resistance to multiple types of stressors, and it must normalize physiological function without favoring any particular direction — meaning it should not simply sedate or stimulate, but rather modulate.

Adaptogenic mushrooms are fungi that meet this definition. Unlike psychoactive mushrooms (which contain psilocybin) or culinary mushrooms consumed primarily for nutrition, adaptogenic mushrooms are prized for their bioactive compounds that interact with the body's stress-regulatory systems.

The primary bioactive compounds identified in most adaptogenic fungi include:

• Beta-glucans: Polysaccharide compounds that modulate immune function and influence neuroendocrine pathways
• Triterpenes: Found especially in reishi; these compounds have demonstrated direct effects on cortisol metabolism and inflammatory signaling
• Ergosterol: A precursor to vitamin D2 found in fungal cell walls, linked to immune and endocrine regulation
• Hericenones and erinacines: Unique to lion's mane; these compounds stimulate nerve growth factor (NGF) synthesis
• Cordycepin: A nucleoside analog found in cordyceps associated with anti-fatigue and anti-inflammatory activity

What distinguishes adaptogenic mushrooms from general health supplements is the specificity of these compounds' interactions with systems governing stress response — particularly the hypothalamic-pituitary-adrenal (HPA) axis, which is the master regulatory circuit controlling cortisol production.

The mushrooms most commonly studied in the context of stress and cortisol include:

1. Reishi (Ganoderma lucidum) — the most extensively researched for HPA axis modulation
2. Lion's Mane (Hericium erinaceus) — primarily studied for its neurological and anxiety-reducing effects
3. Cordyceps (Cordyceps sinensis / militaris) — studied for fatigue, physical stress, and adrenal support
4. Chaga (Inonotus obliquus) — researched for oxidative stress and inflammation linked to chronic cortisol elevation
5. Turkey Tail (Trametes versicolor) — primarily immunological research, with some cortisol-adjacent findings

It is worth noting that the majority of research on adaptogenic mushrooms remains in early stages. Many studies have been conducted in vitro (in cell cultures) or in animal models. Human clinical trials exist but are fewer in number and smaller in scale than those conducted on well-established plant adaptogens. That said, the evidence base is growing meaningfully, and what has emerged in the last decade is compelling enough to warrant serious scientific attention.

Support Your Stress Response, Lower Cortisol and Feel Calmer, Clearer and More Like Yourself Again.

Try our new organic cortisol balance drops risk free

Shop Organic Cortisol Balance Drops

How Mushrooms Influence Cortisol and the HPA Axis

To understand how mushroom adaptogens affect stress at the hormonal level, it helps to first understand the cortisol production pathway.

The HPA Axis: Your Body's Stress Response Circuit

When the brain perceives a stressor, the hypothalamus releases corticotropin-releasing hormone (CRH). CRH signals the pituitary gland to release adrenocorticotropic hormone (ACTH). ACTH then travels through the bloodstream to the adrenal glands, which sit atop the kidneys, prompting them to synthesize and release cortisol.

Cortisol then feeds back to both the hypothalamus and the pituitary in what is called a negative feedback loop — when cortisol rises high enough, it should signal those organs to reduce CRH and ACTH output, thus lowering cortisol naturally. In a healthy, non-chronically-stressed individual, this loop works efficiently.

In people with chronic stress, however, this feedback mechanism becomes dysregulated. The hypothalamus and pituitary become less sensitive to cortisol's inhibitory signal, meaning the system keeps producing CRH and ACTH even when cortisol is already elevated. This leads to sustained high cortisol, which is associated with anxiety, insomnia, metabolic dysfunction, immune suppression, and cognitive decline.

Where Adaptogenic Mushrooms Enter the Picture

Research suggests that adaptogenic mushrooms and cortisol regulation interact at multiple points within this pathway:

1. Modulation of the HPA Axis Sensitivity

The reishi HPA axis connection is perhaps the most mechanistically studied. Triterpenes found in reishi — particularly ganoderic acids — have been shown to influence glucocorticoid receptor sensitivity. This means they may help restore the HPA axis's ability to respond properly to elevated cortisol, effectively re-sensitizing the feedback loop. When the feedback loop works as it should, the body is better able to cap its own cortisol production.

2. Reduction of Upstream Inflammatory Signaling

Chronic low-grade inflammation is both a cause and a consequence of elevated cortisol. Cytokines like IL-6 and TNF-alpha can stimulate hypothalamic CRH release, creating a vicious cycle. The beta-glucans in mushrooms like turkey tail and chaga have demonstrated anti-inflammatory properties in multiple preclinical studies, suggesting they may reduce the inflammatory inputs that drive excess cortisol production.

3. Modulation of the Sympathetic Nervous System

Some research on lion's mane and cordyceps points to effects on the autonomic nervous system, particularly a reduction in sympathetic (fight-or-flight) tone. Since the sympathetic nervous system and the HPA axis operate in tandem during stress, calming sympathetic activity can reduce the overall cortisol burden.

4. Antioxidant Activity and Adrenal Support

Chronic cortisol elevation increases oxidative stress throughout the body, including in the adrenal glands themselves. The high antioxidant content of mushrooms like chaga (which has one of the highest ORAC values of any natural food source) may protect adrenal tissue from oxidative damage, supporting its long-term functional capacity.

5. Neurological Effects on Stress Perception

This is particularly relevant to lion's mane and cortisol research. Lion's mane stimulates the production of nerve growth factor (NGF), which supports the maintenance and growth of neurons in regions of the brain like the hippocampus — a structure that plays a central role in regulating the HPA axis. A healthier hippocampus with better neuronal integrity is associated with more effective HPA axis regulation and lower baseline cortisol.

The picture that emerges from this mechanistic research is not that adaptogenic mushrooms simply "lower cortisol" in a linear, drug-like fashion. Rather, they appear to work as modulators — helping a dysregulated system return toward balance. This is precisely what the original definition of an adaptogen describes: nonspecific normalization rather than directional stimulation or suppression.

Reishi and Cortisol: The Most-Researched Connection

Of all the adaptogenic fungi studied in relation to stress hormones, reishi (Ganoderma lucidum) has the deepest and most consistent evidence base. It has been used in Chinese medicine for over 2,000 years under the name Lingzhi, meaning "mushroom of immortality," and modern pharmacological research has now identified the specific compounds responsible for many of its traditional uses.

Bioactive Compounds Driving Reishi's Anti-Stress Effects

Reishi contains over 400 identified bioactive molecules, but the two most relevant to cortisol research are:

• Ganoderic acids (triterpenes): These steroidal compounds have a structural similarity to human steroid hormones, which may explain their ability to interact with glucocorticoid receptors. Some research suggests they act as mild glucocorticoid receptor modulators, helping normalize receptor sensitivity without fully blocking cortisol's action.
• Polysaccharides (beta-glucans): These modulate immune function and reduce pro-inflammatory cytokine production, indirectly reducing one of the key triggers for excessive HPA axis activation.

Reishi Anti-Stress Research: Clinical Evidence

Reishi anti-stress research has expanded considerably in recent years. A 2020 systematic review by Sanodiya et al. examined 19 clinical trials on Ganoderma lucidum supplementation and confirmed its effectiveness in promoting immune function and reducing fatigue — outcomes closely linked to cortisol normalization. While this review did not focus on cortisol as its primary outcome measure, the fatigue and immune findings are consistent with a cortisol-modulating mechanism.

More directly relevant to the cortisol question is the 2024 study by Mitra S, Mitra M, et al., published in the International Journal of Medicinal Mushrooms (2024; 26(11): 51–64, DOI: 10.1615/IntJMedMushrooms.2024055300). This trial examined the effect of Ganoderma lucidum supplementation on psychological stress and selective fitness profile parameters in female college students in West Bengal, India. The study represents one of the more recent controlled human trials examining reishi cortisol effects specifically in a psychologically stressed but otherwise healthy population — an important distinction from earlier research that focused primarily on clinical or immunocompromised populations.

The findings from this 2024 study added meaningful data to the growing body of reishi anti-stress research, particularly by focusing on the psychological stress dimension rather than only immune or fatigue outcomes. College-aged women represent a population experiencing significant chronic psychosocial stress, making the population highly relevant to everyday use cases for reishi supplementation.

The Reishi HPA Axis Mechanism in Practice

From a clinical standpoint, the reishi HPA axis interaction appears to operate through a combination of the pathways described in the previous section. Specifically:

1. Ganoderic acids may modulate glucocorticoid receptor sensitivity, helping to restore negative feedback regulation
2. Beta-glucans reduce inflammatory signaling that would otherwise stimulate excess CRH release
3. Reishi's established immunomodulatory effects reduce the physiological burden on the HPA axis by keeping immune-inflammatory activation in check

One important nuance from the research: reishi does not appear to suppress cortisol below normal ranges. Rather, the data consistently points toward normalization — bringing elevated cortisol down toward a healthy baseline, without creating adrenal suppression of the kind seen with pharmaceutical corticosteroids. This is consistent with the adaptogenic definition and is a clinically important distinction.

Dosage and Form Considerations

Most clinical research on reishi has used standardized extracts containing a minimum of 10–20% polysaccharides and 1–2% triterpenes. The studies showing meaningful cortisol and stress-related effects have generally used doses in the range of 1,000–5,400 mg of standardized extract per day, though optimal dosing for stress specifically remains an area of ongoing investigation.

Support Your Stress Response, Lower Cortisol and Feel Calmer, Clearer and More Like Yourself Again.

Try our new organic cortisol balance drops risk free

Shop Organic Cortisol Balance Drops

Lion's Mane and Stress: What Research Shows

While reishi dominates the cortisol-specific research, lion's mane stress research has taken a different but equally important angle — focusing on the neurological underpinnings of stress, anxiety, and mood rather than on direct HPA axis modulation.

What Makes Lion's Mane Unique Among Adaptogenic Fungi

Hericium erinaceus, commonly called lion's mane for its distinctive cascading white spines, contains two families of compounds not found in any other mushroom species:

• Hericenones (found in the fruiting body): Stimulate NGF synthesis in the brain
• Erinacines (found in the mycelium): Also stimulate NGF and BDNF (brain-derived neurotrophic factor) synthesis, with erinacines being smaller molecules that can cross the blood-brain barrier more readily

NGF and BDNF are proteins that support the growth, maintenance, and survival of neurons. They are particularly important in the hippocampus — the brain region responsible for memory consolidation, spatial navigation, and, critically for stress research, regulation of the HPA axis.

Lion's Mane and the Hippocampus-HPA Connection

The hippocampus is densely packed with glucocorticoid receptors, making it exquisitely sensitive to cortisol. Under normal conditions, the hippocampus helps turn off the stress response by providing inhibitory input to the hypothalamus once a threat has passed. However, chronic cortisol elevation actually causes hippocampal neurons to atrophy — literally shrinking the brain region responsible for telling the stress response to stop.

This creates a particularly harmful cycle: stress elevates cortisol → cortisol damages the hippocampus → the hippocampus becomes less effective at shutting off the stress response → cortisol remains elevated longer → more hippocampal damage occurs.

By stimulating NGF and BDNF production, lion's mane and cortisol regulation may interact through this hippocampal pathway. If lion's mane can support hippocampal neuronal integrity and even promote neurogenesis in that region, it could theoretically help restore the hippocampus's ability to provide negative feedback to the HPA axis.

Human Clinical Evidence for Lion's Mane Stress Reduction

A landmark double-blind, placebo-controlled clinical trial published in Biomedical Research (Nagano et al., 2010) examined lion's mane's effects on menopause-related symptoms including irritability, anxiety, and poor concentration in 30 women. The lion's mane group showed statistically significant improvements in anxiety and depression scores compared to placebo.

More recent research has examined lion's mane stress outcomes in broader populations. A 2023 randomized controlled trial examined the effects of lion's mane supplementation on self-reported stress and anxiety in healthy young adults, finding significant reductions in anxiety scores after 4 weeks at 1.8g per day of dried mushroom powder. While cortisol was not the primary biomarker measured in this particular trial, the anxiety reduction findings are consistent with a cortisol-modulating mechanism given the well-established relationship between psychological anxiety and cortisol elevation.

Lion's Mane and Cortisol: Direct Evidence vs. Proxy Outcomes

It is important to be precise here. Lion's mane and cortisol research is less direct than reishi research. Most lion's mane studies measure psychological outcomes (anxiety scores, mood ratings, cognitive performance) rather than serum cortisol directly. The cortisol connection is therefore largely inferred from:

1. Known mechanisms involving hippocampal NGF and HPA axis regulation
2. Demonstrated reductions in anxiety and stress symptoms, which are cortisol-correlated
3. Preclinical studies showing cortisol-adjacent neuroendocrine effects in animal models

This distinction matters. It does not make lion's mane less valuable for stress management — in fact, its direct neurological effects may make it particularly valuable for the psychological experience of stress. But it does mean that lion's mane and cortisol should be understood as an indirect rather than direct relationship in the current evidence base.

Cordyceps, Chaga, and Other Adaptogenic Fungi for Stress

Cordyceps: Physical Stress, Fatigue, and the Adrenal Connection

Adaptogenic fungi stress research involving cordyceps has focused primarily on physical rather than psychological stress. A 2016 meta-analysis of 6 randomized clinical trials on Cordyceps sinensis/militaris found significant improvements in VO₂ max — the gold standard measure of aerobic capacity — along with meaningful reductions in exercise-induced fatigue.

This matters for cortisol research because physical exercise is one of the most reliable cortisol triggers. Intense or prolonged exercise activates the HPA axis, causing a significant cortisol spike. While acute exercise-related cortisol rises are generally healthy, athletes training at high volumes are at risk of overtraining syndrome — a state of chronically elevated baseline cortisol that impairs recovery, suppresses immunity, and degrades performance.

Cordyceps supplementation appears to help moderate this exercise-stress cortisol response, likely through two mechanisms:

1. Improved cellular energy efficiency via cordycepin's effects on ATP synthesis, meaning the body perceives a given physical workload as less stressful
2. Direct adrenal support through adrenocortical cell stimulation, which some animal research suggests may help maintain adrenal gland reserve capacity under sustained demand

Cordycepin also has documented anti-inflammatory properties, reducing the cytokine-driven inflammatory signaling that contributes to HPA axis overactivation.

Chaga: Oxidative Stress and Cortisol

Inonotus obliquus, or chaga, grows primarily on birch trees in northern climates and has one of the highest antioxidant concentrations of any natural substance measured by ORAC (Oxygen Radical Absorbance Capacity) values. Its relevance to mushroom adaptogens stress research stems primarily from the relationship between oxidative stress and cortisol.

Elevated cortisol increases the production of reactive oxygen species (free radicals), which damage cell membranes, mitochondria, and DNA throughout the body. Conversely, high oxidative stress can trigger inflammatory cytokine release, which stimulates further cortisol production. Chaga's extraordinarily high antioxidant content — dominated by superoxide dismutase (SOD), melanin, and various phenolic compounds — may help interrupt this oxidative-inflammatory-cortisol cycle.

Chaga also contains betulinic acid and inotodiol, compounds with demonstrated anti-inflammatory properties. While direct cortisol measurement studies on chaga in humans are limited, the preclinical mechanistic evidence supports its inclusion in a comprehensive mushroom adaptogens stress protocol.

Turkey Tail: Immune Stress and Cortisol

Trametes versicolor, known as turkey tail, is perhaps the most immune-focused of the commonly used adaptogenic mushrooms. Its relevance to cortisol research lies in the bidirectional relationship between immune function and cortisol.

Chronic immune activation — whether from persistent infection, autoimmunity, or chronic inflammation — maintains elevated inflammatory cytokines that continuously stimulate HPA axis activity. Turkey tail's potent immunomodulatory polysaccharides (PSK and PSP) help normalize immune function, potentially reducing this inflammatory source of cortisol drive.

Key Clinical Data: Mushroom Cortisol Research in Numbers

For those seeking concrete clinical statistics rather than mechanistic explanation, this section summarizes the most directly measurable findings from mushroom cortisol research to date.

The 2015 Richter et al. Study: The Strongest Direct Cortisol Data

The most statistically significant mushroom cortisol research with direct serum measurements comes from a 2015 study by Richter et al. that examined a mushroom blend supplement (containing Lentinula edodes/shiitake and Grifola frondosa/maitake) in cancer patients.

Key quantitative findings:

| Biomarker | Mushroom Group (6 weeks) | Mushroom Group (12 weeks) | Placebo Group (6 weeks) | Placebo Group (12 weeks) | Statistical Significance | |-----------|--------------------------|---------------------------|-------------------------|--------------------------|--------------------------| | Serum cortisol change | −4.4% | −5.5% | −0.7% | −0.8% | p < 0.001 | | ACTH reduction | −7.9% | — | Minimal | Minimal | Significant | | General fatigue reduction | −19.3% | — | Minimal | Minimal | Significant | | CRP (inflammation) | Significant reduction | — | No significant change | — | p < 0.05 | | Norepinephrine | Decreased | — | No significant change | — | Significant |

The cortisol reductions observed in this study — −4.4% at 6 weeks and −5.5% at 12 weeks — may appear modest in percentage terms. However, several contextual points are important:

1. Statistical significance at p < 0.001 is extremely high — meaning the probability that these differences were due to chance is less than 0.1%
2. The parallel reduction in ACTH (−7.9%) is particularly meaningful because it demonstrates the effect is operating upstream of cortisol production — at the pituitary level — rather than simply altering cortisol metabolism at the adrenal level
3. The accompanying reduction in norepinephrine (a key sympathetic nervous system neurotransmitter) suggests the effect extends beyond the HPA axis to include sympathetic nervous system modulation
4. The 19.3% reduction in general fatigue is clinically significant and likely reflects improved adrenal function and cortisol regulation as a proximal cause

What the Numbers Tell Us About Mechanism

The simultaneous reduction of cortisol and ACTH in the Richter et al. study is mechanistically important. If the mushroom blend were simply affecting cortisol at the adrenal level (for example, by inhibiting cortisol synthesis enzymes), you would expect ACTH to rise reflexively as the pituitary attempts to compensate. Instead, both fell together — suggesting the intervention is working at or above the level of the HPA axis, likely by improving the sensitivity of the HPA feedback loop, as the mechanistic section above describes.

The 2024 Mitra et al. Study: Recent Population Data

The 2024 study by Mitra and colleagues in the International Journal of Medicinal Mushrooms extended reishi research to female college students — a population with high psychological stress burden but without major clinical illness. This population is arguably more representative of the typical adaptogen consumer than the cancer patient cohort in the Richter study. While the specific quantitative cortisol percentage data from this trial requires direct access to the full published text, its existence as a 2024 peer-reviewed controlled trial is significant because it represents the most recent direct human cortisol research on reishi available.

Important Caveats About the Research Landscape

Honest representation of adaptogenic mushrooms cortisol research requires acknowledging its current limitations:

• Most human studies have relatively small sample sizes (often under 100 participants)
• The cancer patient population in the Richter study may not generalize to healthy adults with lifestyle stress
• Standardization of mushroom extracts varies enormously between studies, making comparisons difficult
• Many mechanistic insights come from preclinical (animal or cell culture) studies that have not yet been replicated in large human trials
• Publication bias may mean that negative or null findings are underreported in the literature

These limitations do not invalidate the existing evidence, but they do mean that strong claims about specific percentage reductions should be interpreted cautiously when applying them outside the exact contexts studied.

Support Your Stress Response, Lower Cortisol and Feel Calmer, Clearer and More Like Yourself Again.

Try our new organic cortisol balance drops risk free

Shop Organic Cortisol Balance Drops

Ashwagandha vs Mushroom Adaptogens: How Do They Compare?

One of the most common questions in the adaptogen space is how adaptogenic mushrooms stack up against the most evidence-rich plant-based adaptogens — particularly ashwagandha (Withania somnifera). This comparison is worth making carefully because the two categories have meaningfully different evidence profiles, mechanisms, and practical applications.

Ashwagandha: The Current Gold Standard for Cortisol Evidence

Ashwagandha has arguably the strongest and most consistent human clinical evidence of any adaptogen specifically for cortisol reduction. A frequently cited 2019 double-blind, randomized, placebo-controlled trial by Salve et al. (Medicine, 2019) found that 240mg of ashwagandha root extract daily for 60 days reduced serum cortisol by approximately 23% compared to placebo — a substantially larger effect size than the 5.5% seen in the mushroom blend research.

Other ashwagandha trials have shown:

• 27.9% reductions in perceived stress scores (PSS)
• Significant reductions in serum cortisol ranging from 14.5% to 32.8% across multiple trials
• Improvements in sleep quality, anxiety, and fatigue directly correlated with cortisol normalization

The mechanism involves withanolides — steroidal lactones specific to ashwagandha — that modulate GABA receptors, reduce cortisol synthesis, and help restore HPA axis sensitivity.

Comparing the Evidence Directly

| Factor | Ashwagandha | Adaptogenic Mushrooms | |--------|-------------|----------------------| | Direct cortisol reduction (human RCTs) | Well-established; 14–33% reductions | Emerging; 4–5.5% demonstrated in key trial | | Number of high-quality human trials | 10+ dedicated cortisol RCTs | Fewer; most are small or use composite outcomes | | Mechanism specificity for HPA axis | High; withanolides directly modulate cortisol synthesis | Moderate; beta-glucans and triterpenes work indirectly | | Immune system modulation | Moderate | High (mushrooms are superior here) | | Neurological effects (NGF, cognitive) | Moderate | High (especially lion's mane) | | Safety profile | Strong; generally well-tolerated | Strong; generally well-tolerated | | Gut microbiome support | Limited | Significant (prebiotic beta-glucans) | | Long-term research | More established | Still emerging |

When to Choose Mushrooms Over Ashwagandha, and Vice Versa

The honest answer to the ashwagandha vs mushroom adaptogens question is that they are not direct competitors — they have complementary profiles.

Ashwagandha may be preferable when:

• The primary goal is maximally reducing measurable cortisol levels as quickly as possible
• Anxiety and psychological stress symptoms are dominant
• You want the most evidence-backed single supplement for HPA axis support

Mushroom adaptogens may be preferable when:

• Immune system support is also a priority (mushrooms are substantially superior here)
• Cognitive performance and neurological health are goals alongside stress reduction (lion's mane specifically)
• Physical performance and exercise recovery are concerns (cordyceps specifically)
• You want prebiotic gut microbiome benefits alongside stress support
• You are looking for a more comprehensive, multi-system approach to stress resilience

Both together may be preferable when:

• Comprehensive adaptogenic support is the goal
• Both cortisol normalization and immune-neurological support are priorities
• There are no contraindications (ashwagandha is a nightshade and may not be appropriate for all individuals)

The combination of ashwagandha with adaptogenic mushrooms — often called an "adaptogen stack" in functional medicine — is increasingly common in practice. The theoretical basis for combining them is sound: ashwagandha handles the direct cortisol-suppression angle more potently, while mushrooms contribute immune regulation, gut microbiome support, and neurological benefits that ashwagandha does not provide as robustly.

2024 Research Updates: What's New in the Field

The adaptogenic mushrooms and cortisol research landscape has continued to evolve through 2024 and into 2025, with several meaningful developments worth noting.

The 2024 Mitra Study: Reishi in Healthy Young Women

As noted in the clinical data section, the 2024 publication by Mitra S, Mitra M, et al. in the International Journal of Medicinal Mushrooms (DOI: 10.1615/IntJMedMushrooms.2024055300) represents an important step forward in the reishi cortisol literature. By studying healthy young women — rather than the clinical or elderly populations that dominated earlier research — this trial expands the applicability of findings to a much larger demographic of potential adaptogen users.

The focus on "psychological stress and selective fitness profile parameters" in female college students acknowledges something that previous clinical research often overlooked: stress is not only a concern for people with diagnosable health conditions. The vast majority of people seeking adaptogenic support are healthy individuals dealing with the chronic low-grade stress of academic pressure, professional demands, relationship challenges, and lifestyle disruption. Research in this population is therefore highly valuable for informing practical recommendations.

2023–2024 Systematic Reviews on Adaptogens and Cortisol

A systematic review and meta-analysis examining "the effect of adaptogenic plants on stress" — published in 2023 and widely cited in 2024 contexts — examined effects on cortisol and related hormone levels across multiple adaptogenic interventions. While this review covered the broader adaptogen category (including both mushrooms and plant-based adaptogens), its inclusion of adaptogenic mushrooms cortisol data alongside plant adaptogens provides important comparative context.

The review's findings reinforced several key patterns observed across the individual studies:

1. Cortisol reductions associated with adaptogen use tend to be most pronounced in populations with documented elevated baseline cortisol
2. Duration of supplementation matters — effects at 8–12 weeks are generally stronger than effects at 4 weeks
3. The standardization and quality of the extract used is a significant determinant of outcomes
4. Combination products (multiple adaptogenic ingredients) do not always outperform single-ingredient approaches and can make attribution of specific effects difficult

What's Still Missing: Research Gaps as of 2025–2026

For a complete picture of the adaptogenic mushrooms and cortisol research landscape, it is worth acknowledging what we still do not know:

1. Long-term cortisol data beyond 12 weeks is largely absent. The Richter study ran to 12 weeks; most others are 4–8 weeks. We do not yet have robust evidence for what happens to cortisol levels with 6–12 months of consistent mushroom supplementation.

1. Dose-response relationships are poorly defined. We know approximately which dose ranges produce effects, but we do not have the kind of detailed dose-response curves that would allow precise dosing recommendations for specific cortisol targets.

1. Head-to-head comparison trials between different mushroom species (e.g., reishi vs. lion's mane vs. cordyceps) for cortisol specifically are virtually nonexistent. Most trials use single species or blends.

1. Bioavailability studies comparing different extraction methods (hot water, dual extraction, fermentation) and their respective effects on cortisol-relevant biomarker outcomes are limited.

1. Large-scale RCTs in healthy working adults — arguably the most commercially relevant population — are still lacking. Most evidence comes from clinical populations or small student cohorts.

These gaps do not negate the existing evidence. They simply define the research agenda for the coming years, and several trials currently in registration suggest these questions are beginning to be addressed.

Are Adaptogenic Mushrooms Safe for Long-Term Use?

Safety is an essential consideration when evaluating any supplement intended for long-term use in otherwise healthy individuals. The mushroom adaptogens stress literature, taken as a whole, presents a reassuring safety profile with some important nuances.

General Safety Profile

The foundational criterion for adaptogen classification — that a substance must be "nontoxic at normal doses" — has been broadly supported for the commonly used adaptogenic fungi. Multiple safety reviews and clinical trials have reported:

• No significant adverse events in trials using standard doses of reishi, lion's mane, or cordyceps for up to 12 weeks
• No evidence of adrenal suppression (unlike pharmaceutical corticosteroids, adaptogenic mushrooms do not appear to reduce the adrenal gland's own cortisol production capacity)
• No significant drug interactions identified at typical supplement doses, though theoretical interactions exist with anticoagulants (reishi) and immunosuppressants
• No organ toxicity (hepatic or renal) reported at standard doses in available studies

Specific Safety Considerations by Species

Reishi: The most commonly reported side effects at higher doses include digestive discomfort and, rarely, dry mouth. In persons with autoimmune conditions, the immunostimulatory effects warrant monitoring. Reishi has mild platelet-aggregation-inhibiting properties that theoretically could interact with blood-thinning medications — anyone on anticoagulants should consult a physician before use.

Lion's Mane: Has an excellent safety profile with few reported adverse events. Rare cases of allergic reactions have been documented, primarily in individuals with other fungal allergies. No significant drug interactions are established.

Cordyceps: Well-tolerated in clinical studies. Because of its mild stimulant-like properties related to ATP synthesis, some individuals report insomnia when taken later in the day.

Chaga: One safety consideration specific to chaga is its high oxalate content, which could theoretically increase kidney stone risk in susceptible individuals with a history of calcium-oxalate stones if consumed in very high amounts.

The Question of Immunostimulation

A nuanced safety consideration for all adaptogenic fungi is their immunomodulatory activity. For most people, immune modulation is beneficial — supporting immune surveillance and reducing chronic low-grade inflammation. However, for individuals with autoimmune conditions (rheumatoid arthritis, lupus, multiple sclerosis, inflammatory bowel disease), substances that stimulate immune function warrant caution and medical oversight, as they could theoretically worsen autoimmune activity.

This is not a contraindication per se — some adaptogenic mushrooms actually demonstrate immunomodulatory effects that include both stimulation and suppression depending on the immune context. But it is a reason for individuals with autoimmune conditions to consult a healthcare provider before adding adaptogenic mushroom supplements to their routine.

Can Adaptogens Replace Medical Treatment for Chronic Stress?

This is a question that both clinicians and consumers need to answer clearly: No. Adaptogenic mushrooms are supplements. They are not FDA-approved treatments for any medical condition, including anxiety disorders, depression, or adrenal dysfunction. They should be considered supportive tools within a comprehensive approach to stress management that includes:

• Evidence-based psychological interventions (cognitive behavioral therapy, mindfulness-based stress reduction)
• Lifestyle factors (sleep hygiene, regular physical activity, social connection)
• Medical evaluation for persistent or severe stress-related symptoms
• Nutritional optimization

The clinical evidence for adaptogenic mushrooms cortisol reduction is promising and, in several studies, statistically significant. But a 5.5% cortisol reduction, while meaningful, is not the same as treating clinical hypercortisolemia (Cushing's syndrome) or a diagnosed anxiety disorder. Setting appropriate expectations is important both for individual users and for the integrity of the field.

How to Choose and Use Mushroom Adaptogens for Stress

Given the research landscape reviewed above, how should a practitioner or health-conscious individual approach selecting and using mushroom adaptogens for stress and cortisol regulation practically?

Step 1: Define Your Primary Stress-Related Goal

Different mushrooms excel for different aspects of the stress response:

| Goal | Best-Supported Mushroom Choice | |------|-------------------------------| | Reduce elevated cortisol (direct HPA axis effect) | Reishi | | Reduce anxiety and psychological stress perception | Lion's Mane | | Improve physical stress resilience and exercise recovery | Cordyceps | | Reduce inflammatory burden driving cortisol elevation | Chaga or Turkey Tail | | Comprehensive immune + stress support | Multi-mushroom blend |

Step 2: Prioritize Extract Quality and Standardization

The difference between a high-quality mushroom extract and a low-quality one can be the difference between meaningful cortisol effects and none at all. Key quality markers include:

• Fruiting body vs. mycelium: Most research has been conducted on fruiting body extracts. Products using myceliated grain (mycelium grown on oats or rice) contain much lower concentrations of bioactive compounds and significantly higher starch content. Look for products that specify "fruiting body" in their sourcing.
• Beta-glucan content: Aim for products that specify a minimum beta-glucan percentage (typically 20–30% for high-quality reishi and lion's mane extracts). Polysaccharide percentage is sometimes listed instead — look for 30% or higher.
• Triterpene content for reishi: Look for products specifying at least 1–2% triterpenoid content, which requires proper dual extraction (hot water + alcohol).
• Third-party testing: Heavy metals, pesticides, and mycotoxins are legitimate concerns with mushroom products. Look for Certificates of Analysis (COA) from independent labs.
• Dual-extraction vs. hot-water-only: For reishi specifically, the triterpenes responsible for many of its cortisol-relevant effects are not water-soluble. They require alcohol extraction. A product that is only hot-water extracted will capture beta-glucans but miss triterpenes. Dual-extraction products contain both.

Step 3: Choose an Appropriate Dose and Duration

Based on clinical research, the following dosage ranges represent a reasonable starting point for stress and cortisol support:

• Reishi: 1,000–5,400mg standardized extract per day (split into 2 doses); research suggests at least 6–12 weeks needed for measurable cortisol effects
• Lion's Mane: 1,000–3,000mg fruiting body extract per day; neurological effects may take 4–8 weeks
• Cordyceps: 1,500–3,000mg standardized extract per day; physical performance effects often noted within 2–4 weeks

Step 4: Timing Matters

• Reishi is often taken in the evening, as it has mild calming properties that may support sleep quality — itself an important factor in cortisol regulation
• Lion's mane can be taken morning or afternoon, as its effects are cognitive-supportive rather than sedating
• Cordyceps is best taken in the morning or pre-workout, as its energizing properties may interfere with sleep if taken late

Step 5: Monitor and Adjust

For individuals serious about tracking cortisol outcomes, a salivary cortisol test (measuring cortisol at 4 points throughout the day to assess the daily cortisol curve) provides a useful baseline and follow-up measure at 8–12 weeks. This is available through many functional medicine practitioners and direct-to-consumer lab testing services.

Support Your Stress Response, Lower Cortisol and Feel Calmer, Clearer and More Like Yourself Again.

Try our new organic cortisol balance drops risk free

Shop Organic Cortisol Balance Drops

Frequently Asked Questions

Q: How do adaptogenic mushrooms lower cortisol levels?

A: Adaptogenic mushrooms influence cortisol through several interconnected mechanisms rather than a single direct pathway. The primary mechanism involves modulation of the HPA axis — the hormonal circuit that controls cortisol production. Beta-glucans in mushrooms reduce the pro-inflammatory cytokines that stimulate excess HPA axis activation. Triterpenes in reishi (ganoderic acids) appear to help restore sensitivity in the negative feedback loop, allowing the body to more effectively shut off cortisol production once a stressor has passed. Lion's mane works through a different pathway, supporting hippocampal neuronal health via nerve growth factor stimulation, which indirectly improves the hippocampus's ability to regulate HPA axis activity. The net effect across these mechanisms is normalization of cortisol — bringing elevated levels toward a healthy baseline rather than artificially suppressing cortisol below normal ranges.

Q: Which mushroom is best for stress and anxiety?

A: For directly reducing measurable cortisol levels, reishi has the strongest human clinical evidence, including the landmark Richter et al. study showing statistically significant reductions in both cortisol (−5.5% at 12 weeks) and ACTH (−7.9%). For the psychological experience of stress and anxiety, lion's mane has produced the most consistent results in clinical trials measuring anxiety and mood scores, likely through its neurological effects on the hippocampus. For stress related to physical performance and exercise, cordyceps is the most researched. Many practitioners and formulation experts recommend a combination of all three — sometimes called a "stress trinity" — to address multiple dimensions of the stress response simultaneously. Your best choice depends on your primary concern: hormonal cortisol levels (reishi), psychological anxiety (lion's mane), or physical stress resilience (cordyceps).

Q: Are adaptogenic mushrooms better than ashwagandha for cortisol?

A: This is the ashwagandha vs mushroom adaptogens question that many health-conscious consumers face. Ashwagandha currently has more direct human clinical evidence for cortisol reduction specifically, with studies showing 14–33% reductions in serum cortisol compared to the 4–5.5% seen in the best mushroom cortisol trial. However, "better" depends entirely on your goals. Adaptogenic mushrooms are superior to ashwagandha for immune system support, prebiotic gut effects, and neurological benefits (particularly lion's mane). Ashwagandha is more potent for direct cortisol reduction and has a more established evidence base for anxiety. Many functional medicine practitioners now recommend combining both categories rather than choosing between them, with ashwagandha handling the direct HPA axis suppression and mushrooms contributing immune, neurological, and microbiome benefits.

Q: How long does it take for adaptogenic mushrooms to reduce cortisol?

A: Based on the available clinical data, meaningful cortisol changes require consistent supplementation for 6–12 weeks at minimum. The Richter et al. study found a −4.4% cortisol reduction at 6 weeks, which increased to −5.5% at 12 weeks — suggesting continued benefit with extended use. Subjective improvements in stress, sleep, and energy are often reported earlier (within 2–4 weeks), but measurable biomarker changes take longer to manifest. This timeline is consistent with other adaptogenic interventions and reflects the gradual nature of HPA axis recalibration. Quick results should not be expected from mushroom adaptogens; their value is in long-term resilience building rather than acute cortisol suppression.

Q: Can adaptogenic mushrooms replace stress medications or therapy?

A: No. Adaptogenic mushrooms are dietary supplements, not pharmaceutical treatments, and should not replace evidence-based medical or psychological treatments for clinical stress disorders, anxiety disorders, or depression. They can be a valuable complementary strategy within a comprehensive approach that includes appropriate medical care, psychological support, sleep optimization, exercise, and nutritional strategies. Anyone using adaptogenic mushrooms while taking prescription medications — particularly immunosuppressants, anticoagulants, or psychiatric medications — should consult their healthcare provider regarding potential interactions before starting supplementation.

Q: Is the mushroom cortisol research strong enough to trust?

A: The mushroom cortisol research base is genuine, peer-reviewed, and shows statistically significant results in the trials that have been conducted. However, intellectual honesty requires acknowledging its current limitations: most human trials are small, several key findings come from specific populations (cancer patients, college students) that may not generalize universally, and many mechanistic insights still come from preclinical rather than human studies. The evidence is strong enough to support using adaptogenic mushrooms as part of a stress management strategy, but it is not yet strong enough to support highly specific clinical claims. The field is growing — the 2024 Mitra study and ongoing trials are adding to the foundation — and the direction of the evidence is consistently positive.

Q: Are there any side effects from taking adaptogenic mushrooms for stress?

A: Adaptogenic mushrooms have a generally excellent safety profile at normal supplemental doses. Reported side effects are uncommon and typically mild, including digestive discomfort, dry mouth (with reishi), and rare allergic reactions in individuals with fungal sensitivities. No significant organ toxicity or drug interactions have been established in clinical trials at standard doses, though theoretical interaction with anticoagulants (reishi has mild blood-thinning properties) warrants caution. Individuals with autoimmune conditions should consult a physician before use due to immune-modulating effects. Long-term safety data beyond 12 weeks is limited in the formal research, though many traditional medicine systems have a centuries-long history of use without notable safety signals emerging in the literature.

Final Thoughts

The science of adaptogenic mushrooms and cortisol research stands at an interesting inflection point in 2025. The evidence is no longer merely traditional or anecdotal. There are now peer-reviewed, randomized, placebo-controlled human clinical trials showing statistically significant reductions in serum cortisol, ACTH, and inflammatory biomarkers in response to mushroom supplementation. The mechanistic picture — involving HPA axis modulation, inflammatory cytokine reduction, hippocampal neurotrophin support, and sympathetic nervous system calming — is increasingly coherent and well-supported across multiple research programs.

At the same time, the evidence base remains younger and thinner than what exists for pharmaceutical stress interventions or even for plant-based adaptogens like ashwagandha. The most compelling mushroom cortisol research to date — the Richter et al. 2015 study — showed a meaningful but modest 5.5% cortisol reduction. The 2024 Mitra study on reishi in healthy college women represents the kind of population-broadening research that is needed to move the field forward. More of this work is needed.

What seems clear from the cumulative evidence is that adaptogenic fungi for stress work best understood as system-level modulators rather than targeted cortisol-lowering drugs. Their value is in helping a dysregulated stress-response system return toward balance — supporting the biological infrastructure of resilience rather than forcing a specific hormonal outcome. This is, in many ways, precisely what comprehensive stress management requires.

Reishi provides the most direct HPA axis and cortisol-relevant effects. Lion's mane addresses the neurological underpinnings of stress perception and hippocampal health. Cordyceps builds physical stress resilience and adrenal support for those under athletic or high-exertion demands. Together, these adaptogenic mushrooms form a coherent, complementary framework for addressing chronic stress from multiple biological angles.

Whether used individually or in combination — and whether used alongside or instead of plant-based adaptogens like ashwagandha — the research supports giving adaptogenic mushrooms a legitimate seat at the functional medicine table for cortisol and stress management. The invitation is to engage with them not with blind faith in ancient tradition or uncritical acceptance of marketing claims, but with the measured, evidence-calibrated confidence that the emerging science increasingly warrants.

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before beginning any new supplement regimen, particularly if you have existing health conditions or are taking prescription medications.

References:

1. MindLabPro. "Benefits of Adaptogenic Mushrooms." https://www.mindlabpro.com/blogs/nootropics/benefits-of-adaptogenic-mushrooms
2. NIH / PMC Clinical Trial Report. https://pmc.ncbi.nlm.nih.gov/articles/PMC12808922/
3. Dr. Ruscio. "Adaptogenic Mushrooms." https://drruscio.com/adaptogenic-mushrooms/
4. Richter et al. (2015). Mushroom blend supplementation, cortisol and ACTH biomarker analysis in cancer patients.
5. Sanodiya et al. (2020). Systematic review of 19 clinical trials on Ganoderma lucidum.
6. Nagano M et al. (2010). "Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake." Biomed Res.
7. Mitra S, Mitra M, et al. (2024). "Efficacy of Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum Supplementation on Psychological Stress and Selective Fitness Profile Parameters in Female College Students in West Bengal, India." Int J Med Mushrooms. 26(11): 51–64. DOI: 10.1615/IntJMedMushrooms.2024055300
8. Salve J et al. (2019). "Adaptogenic and Anxiolytic Effects of Ashwagandha Root Extract in Healthy Adults." Medicine (Baltimore).
9. 2016 Meta-analysis of 6 RCTs on Cordyceps and VO₂ max.
10. 2023 Systematic review and meta-analysis: "The effect of adaptogenic plants on stress."